Journal
FIBERS AND POLYMERS
Volume 19, Issue 7, Pages 1444-1453Publisher
KOREAN FIBER SOC
DOI: 10.1007/s12221-018-8037-y
Keywords
Drug-eluting stent; Electrospinning; Polymeric stent; Poly-lactic acid; Chitosan
Categories
Ask authors/readers for more resources
Electrospun composite fibers of poly-lactic acid (PLA), chitosan (Ch) and paclitaxel (PTX) were fabricated for surface covering of a polymeric prototype PLA stent by means of single nozzle electrospinning approach to prepare a low cytotoxicity drug-eluting stent. Different concentrations of the drug (40 %, 60 %, 80 %, 100 % and 120 %) and chitosan (3 %, 5 %, 7 % and 9 %) were incorporated to reach the optimum composite fibers. The electrospun composite fibers were subjected to detailed analyses including scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), tensile test, MTT assay, cell culture and in vitro drug release. Results have confirmed a proper physical encapsulation of PTX in the polymeric matrix in which no chemical bonding was detected between the polymers and the drug. Among the fabricated composite fibers, specimens including 40 % and 60 % drug also exhibited an excellent cytotoxicity and controlled drug release. SEM images have proved the effect of paclitaxel in resisting cell adhesion and propagation on the fibers. Findings from this study suggest a novel polymer/drug coating that could be potentially applicable in surface covering of polymeric stents e.g. PLA stents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available